r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SL

Shao-Lee Lin

Insider · Chief Executive Officer · CUE

Shao-Lee Lin files insider transactions with the SEC as a chief executive officer of Cue Biopharma (CUE). We hold 2 disclosed purchases and sales filed since 5 January 2018, 2 of them in the last 90 days.

  • Files forCUE
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure14 August 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 May 2026 — 13 August 2026Chief Executive Officer · Cue Biopharma (CUE)15 Form 4 lines · source: SEC Form 4
  • Filed 7 June 2022 — 14 May 2025Director · Surrozen, Inc./DE (SRZN)4 Form 4 lines · source: SEC Form 4
  • Filed 4 May 2023 — 1 April 2024Chief Executive Officer · Acelyrin (SLRN)27 Form 4 lines · source: SEC Form 4
  • Filed 26 October 2022 — 26 October 2022Director · Third Harmonic Bio (THRD)1 Form 4 line · source: SEC Form 4
  • Filed 16 April 2019 — 28 September 2020Director · Principia Biopharma (PRNB)6 Form 4 lines · source: SEC Form 4
  • Filed 4 January 2018 — 21 January 2020EVP, Head of R&D and CSO · Horizon Therapeutics Public Ltd Co (HZNP)24 Form 4 lines · source: SEC Form 4

Everything they disclosed

77 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.